THOR-213

N/A

Report date: 2024/12/06 09:47:07
NME

Base Information

Drug NameTHOR-213
Drug Alias NameTHOR-213
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionMacrophage migration inhibitory factor inhibitorsHLA-DR antigens-associated invariant chain agonists
TargetsMacrophage migration inhibitory factorHLA-DR antigens-associated invariant chain
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThor therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesThor therapeutics Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A